Dr Muddukrishna Badamane Sathyanarayana
Associate Professor
Date of Joining : 05.07.2010
Department of Pharmaceutical Quality Assurance
CURRENT ACADEMIC ROLE & RESPONSIBILITIES
Muddukrishna Badamane Sathyanarayana is involved in planning and organising day-to-day research activities.
He participates actively in scientific investigation and learning research techniques. He supervises analytical work and documentation as per pharmaceutical industry regulations.?
SUBJECTS CURRENTLY TEACHING
| Subject | Semester / Year |
|---|---|
| Pharmaceutical Analysis | Third year PharmD |
| Pharmaceutical Analysis Lab | Third year PharmD |
| Quality Management Systems | MPharm- First semester |
| Pharmaceutical Quality Assurance practicals | MPharm- First semester |
ACADEMIC QUALIFICATIONS
| Degree | Specialisation | Institute | Year of passing |
|---|---|---|---|
| Ph.D. | Pharmaceutical Sciences | 365体育投注 Academy of Higher Education | 2017 |
| MPharm (Master in Pharmacy) | Pharmaceutical Analysis and Pharmaceutical Chemistry | Rajiv Gandhi University of Health Sciences, Bangalore | 2009 |
Experience
| Institution / Organisation | Designation | Role | Tenure |
|---|---|---|---|
| Department of Pharmaceutical Quality Assurance, MCOPS, 365体育投注 Academy of Higher Education | Lecturer | July 2009-Januray 2013 |
AREAS OF INTEREST, EXPERTISE AND RESEARCH
Area of Expertise
Co Crystal Technology, Solubility Enhancement, Pharmacokinetic Studies, Stability Indicating Assay Methods
Professional Affiliations & Contributions
Muddukrishna has a strong track record in research both in industry and academics, He is an asset for any institution with his nearly 15+ years of exposure in 365体育投注 & Development, Laboratory Operations & Quality Assurance in an organization of high repute. ?
Presently he is focused in the synthesis and characterization of pharmaceutical materials, including synthesis and characterization of cocrystals. Muddukrishna has published articles in various international peer reviewed journals, he is also a reviewer for various Indian and international journals.
The author credentials and citation graphs can be accessed by following platforms,
SCOPUS AUTHOR ID: 55234164200
ORCID ID: orcid.org/0000-0001-6447-5759
GOOGLE SCHOLAR LINK: https://scholar.google.co.in/citations?user=gubxuTQAAAAJ&hl=en
Peer review record can be verified at: PUBLON ID: ?publons.com/a/735512/
Connect, collaborate and share your research experience at: RESEARCH GATE LINK: https://www.researchgate.net/profile/Muddu_Krishna3
MENDELEY LINK: https://www.mendeley.com/profiles/muddukrishna-badamane-sathyanarayan/
Work Experience
| Organisation | Role | Tenure |
|---|---|---|
| Bangalore Pharmaceuticals and 365体育投注 Laboratories, Bangalore | Quality Control Executive | |
| ZydusCadila 365体育投注 Centre, Bangalore | Assistant Manager - Analytical Development | |
| EcronAcuNova, 365体育投注 | Assistant Manager - Bio analytical department | |
| Stabicon Life Sciences, Bangalore | Manager - Analytical Development |
Fabrication, solid state characterization and bioavailability assessment of stable binary amorphous phases of Ritonavir with Quercetin
2015-15-01 Syed Sajjad Hussen Muddukrishna Badamane Sathyanarayana Prashant B. Musmade Gautham Shenoy G Krishnamurthy Bhat
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 89, Impact factor: 4.394
Preparation and characterization of co-amorphous Ritonavir–Indomethacin systems by solvent evaporation technique: Improved dissolution behaviour and physical stability without evidence of intermolecular interactions
2014-15-06 Om Prakash Ranjan Syed Sajjad Hussen Muddukrishna Badamane Sathyanarayana Gautham Shenoy G Krishnamurthy Bhat
European Journal of Pharmaceutical Sciences, Vol.62, Impact factor: 3.463
Estimation of Stavudine, Lamivudine and Nevirapine by Chemometric UV Spectroscopic Method.
2012-01-01 Abhilasha Gupta Bhagawati ST Muddukrishna Badamane Sathyanarayana Jagadish P C Krishnamurthy Bhat
Indian Journal of Pharmaceutical Education and 365体育投注, Vol.4, Impact Factor: 0.54
Development of a sensitive bioanalytical method for the quantification of lacosamide in rat plasma.
2012-01-01 Shah SK SG Vasantharaju Karthik A Muddukrishna Badamane Sathyanarayana Desai N.
Arzneimittelforschung, Vol.62, Impact Factor: 0.50
Preparation and Solid State Characterization of Paclitaxel Cocrystals.
2014-01-01 Muddukrishna Badamane Sathyanarayana Krishnamurthy Bhat Gautham Shenoy G
365体育投注 Journal of Pharmacy and Technology, Vol. 7
Regulatory insights for filling variation and managing post approval CMC changes: comparison of latest US FDA and EMA guidelines and an outlook on other international and emerging markets
Drug Regulatory Affairs Shagufta Khan
MPharm II (Drug Regulatory Affairs) 2014-15
Regulatory requirement for product submission in MEA countries and general checklist of CMC data for ROW.
Drug Regulatory Affairs Kushal Bohra
MPharm II (Drug Regulatory Affairs) 2014-15
Introspective study of newly adopted bioequivalence guidance by EU regulatory on MR products, Canadian Regulatory on Comparative bioavailability studies and ANDA submissions ; Refuse to receive standards by USFDA, A comparative insights
Drug Regulatory Affairs Ankita Rastogi
MPharm II (Drug Regulatory Affairs) 2014-15
Stability indicating method for the estimation of saroglitazar in bulk drug and in pharmaceutical formulation by RP-HPLC
Pharmaceutical Quality Assurance Purva Gupta
MPharm II (Pharmaceutical Quality Assurance) 2014-15
Stability indicating assay method development and validation of Aprepitant by RP-HPLC
Pharmaceutical Quality Assurance Raghavendra B.
MPharm II (Pharmaceutical Quality Assurance) 2014-15